check_circleStudy Completed

Diabetes Mellitus

GlucoFriend-evaluation the effectiveness of Glucobay when combined with a basal insulin

Trial purpose

To evaluate the effectiveness of Glucobay when combined with a basal insulin under daily-life treatment conditions in a large sample of Korean patients.

Key Participants Requirements

Sex

Both

Age

18 - N/A
  • - Signed written informed consent
    - Age ≥ 18 years
    - Diagnosed of type 2 diabetes for at least 6 months prior to enrollment
    - Patients treated with stable dose of a basal insulin (insulin glargine or insulin detemir) at least 2 months
    - HbA1C≥7.5 and ≤10.0%

  • - Exclusion criteria must be read in conjunction with the local product information

Trial summary

Enrollment Goal
539
Trial Dates
September 2010 - July 2012
Phase
N/A
Could I Receive a placebo
No
Products
Acarbose (Precose/Glucobay, BAYG5421)
Accepts Healthy Volunteer
No

Where to participate

StatusInstitutionLocation
Completed
Many Locations, Korea, Republic Of

Primary Outcome

  • Change in HbA1c
    date_rangeTime Frame:
    After 20 weeks
    enhanced_encryption
    Safety Issue:
    No

Secondary Outcome

  • Duration and dose of acarbose treatment
    date_rangeTime Frame:
    After 20 weeks
    enhanced_encryption
    Safety Issue:
    No
  • Postprandial Blood Glucose
    date_rangeTime Frame:
    After 20 weeks
    enhanced_encryption
    Safety Issue:
    No

Trial design

Combined use of a basal insulin and Glucobay For reducing PPG to end diabetes progress
Trial Type
Observational
Intervention Type
Drug
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A